1. Home
  2. TECX vs MIN Comparison

TECX vs MIN Comparison

Compare TECX & MIN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Tectonic Therapeutic Inc. Common Stock

TECX

Tectonic Therapeutic Inc. Common Stock

HOLD

Current Price

$20.98

Market Cap

359.0M

Sector

N/A

ML Signal

HOLD

Logo MFS Intermediate Income Trust

MIN

MFS Intermediate Income Trust

HOLD

Current Price

$2.66

Market Cap

302.7M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
TECX
MIN
Founded
2019
1988
Country
United States
United States
Employees
N/A
N/A
Industry
Trusts Except Educational Religious and Charitable
Sector
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
359.0M
302.7M
IPO Year
2018
N/A

Fundamental Metrics

Financial Performance
Metric
TECX
MIN
Price
$20.98
$2.66
Analyst Decision
Strong Buy
Analyst Count
5
0
Target Price
$81.20
N/A
AVG Volume (30 Days)
407.9K
331.0K
Earning Date
11-06-2025
01-01-0001
Dividend Yield
N/A
7.31%
EPS Growth
N/A
N/A
EPS
N/A
0.08
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
$33.38
Revenue Growth
N/A
N/A
52 Week Low
$13.70
$2.52
52 Week High
$61.07
$2.88

Technical Indicators

Market Signals
Indicator
TECX
MIN
Relative Strength Index (RSI) 59.16 57.71
Support Level $18.60 $2.63
Resistance Level $22.00 $2.67
Average True Range (ATR) 1.72 0.02
MACD 0.09 0.00
Stochastic Oscillator 78.88 83.33

Price Performance

Historical Comparison
TECX
MIN

About TECX Tectonic Therapeutic Inc. Common Stock

Tectonic Therapeutic Inc is a biotechnology company focused on the discovery and development of therapeutic proteins and antibodies that modulate the activity of GPCRs. Its technology platform called GEODe, Tectonic is focused on developing biologic medicines that overcome the existing challenges of GPCR-targeted drug discovery to modify the course of disease. Company focus on areas of important unmet medical need, often where therapeutic options are poor or nonexistent, and where new medicines have the potential to improve patient quality of life or extend duration of life. Pipeline includes TX000045, Group 2 PH, TX2100: GPCR Antagonist for Hereditary Hemorrhagic Telangiectasia (HHT), Fibrosis.

About MIN MFS Intermediate Income Trust

MFS Intermediate Income Trust is a diversified closed-end management investment company. The fund's investment objective is to seek high current income but may also consider capital appreciation. It invests the assets in debt instruments. Its portfolio of investments comprises of different sector investments such as the automotive, chemicals, energy, food and beverages, insurance, and other sectors.

Share on Social Networks: